LanZhou Foci Pharmaceutical Co.,Ltd. (SHE:002644)

China flag China · Delayed Price · Currency is CNY
7.33
+0.17 (2.37%)
Jul 3, 2026, 3:04 PM CST
Market Cap3.74B -16.6%
Revenue (ttm)910.98M -1.2%
Net Income52.49M -14.0%
EPS0.10 -14.0%
Shares Out 510.66M
PE Ratio71.30
Forward PEn/a
Dividend0.02 (0.27%)
Ex-Dividend DateJun 26, 2026
Volume4,131,700
Open7.19
Previous Close7.16
Day's Range7.15 - 7.35
52-Week Range6.63 - 11.85
Beta0.24
Analystsn/a
Price Targetn/a
Earnings DateAug 20, 2026

About SHE:002644

LanZhou Foci Pharmaceutical Co.,Ltd., research and development, production, and sales of traditional Chinese medicines and health products in China. The company offers its products in various dosage forms, including pills, tablets, granules, capsules, and gelatin under the MingShan, BaoShu, BaoLu, and Foci brands. It also engages in planting and selling of Chinese medicinal materials; pre-packaged food; processing and selling of Chinese herbal medicine pieces; technology development, and professional and technical services; inspection and testi... [Read more]

Sector Healthcare
Founded 1929
Employees 1,332
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002644
Full Company Profile

Financial Performance

In 2025, SHE:002644's revenue was 915.53 million, a decrease of -6.60% compared to the previous year's 980.23 million. Earnings were 49.21 million, a decrease of -18.08%.

Financial Statements